Expanded Physiologically‐Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction

As rifampicin can cause the induction and inhibition of multiple metabolizing enzymes and transporters, it has been challenging to accurately predict the complex drug–drug interactions (DDIs). We previously constructed a physiologically‐based pharmacokinetic (PBPK) model of rifampicin accounting for...

Descripción completa

Detalles Bibliográficos
Autores principales: Asaumi, Ryuta, Menzel, Karsten, Lee, Wooin, Nunoya, Ken‐ichi, Imawaka, Haruo, Kusuhara, Hiroyuki, Sugiyama, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875706/
https://www.ncbi.nlm.nih.gov/pubmed/31420941
http://dx.doi.org/10.1002/psp4.12457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875706/
https://www.ncbi.nlm.nih.gov/pubmed/31420941
http://dx.doi.org/10.1002/psp4.12457

Ejemplares similares